Netherlands (Kingdom of the) vs Sweden: Percentage of bloodstream infection due to methicillin-resistant
Netherlands (Kingdom of the)
2.3%
in 2022
Sweden
1.9%
in 2022
Netherlands (Kingdom of the) rank
47th
Sweden rank
48th
Percentage of bloodstream infection due to methicillin-resistant over time
- Netherlands (Kingdom of the)
- Sweden
How they compare
Netherlands (Kingdom of the) currently reports 2.3% against 1.9% in Sweden, a difference of 0.4%.
That makes Netherlands (Kingdom of the)'s figure about 1.2 times Sweden's.
The two have swapped places 2 times across 6 shared years of data; in 2017 it was Netherlands (Kingdom of the) ahead.
Netherlands (Kingdom of the) ranks 47th and Sweden ranks 48th of 50 countries.
Sweden has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Netherlands (Kingdom of the) | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.4% | 1.6% | 0.2% | Sweden |
| 2020s | 1.8% | 3.0% | 1.2% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, Netherlands (Kingdom of the) or Sweden?
- Netherlands (Kingdom of the), at 2.3% against 1.9% in Sweden as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between Netherlands (Kingdom of the) and Sweden?
- 0.4%, with Netherlands (Kingdom of the) ahead.
- How many years of comparable data are there for Netherlands (Kingdom of the) and Sweden?
- 6 years are reported by both, from 2017 to 2022.
- How do Netherlands (Kingdom of the) and Sweden rank globally for percentage of bloodstream infection due to methicillin-resistant?
- Netherlands (Kingdom of the) ranks 47th and Sweden ranks 48th of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.